Lastly, KEGG analysis further validated the connection of MMP2, MMP9, MMP12, and MMP16 hub genes with different cancer-driving pathways, such as “Bladder cancer, endocrine resistance, and relaxin signaling pathways.” The gene discussed is MMP2; the disease is urinary bladder cancer.